Tenderwize
Back to tender search

Open House Biologika Rabattverträge 2026 - 15 Ranibizumab

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 30, 2027 · 316 days left·Open·Supplies
Sign up to saveOpen documents
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 15 Ranibizumab

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or volume provided – cannot assess potential revenue.

All eligible competitors can participate; high competition may reduce market share.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Supply of Ranibizumab pharmaceutical products under discount contracts.
Show full summary

Open-house procedure by Techniker Krankenkasse (TK) and other German health insurers to conclude discount contracts (Rabattverträge) under §130a Abs. 8 SGB V for the active substance Ranibizumab. The contract is non-exclusive, uniform terms, no negotiation, maximum 12-month term starting 01.07.2026. Submission is possible at any time during the contract period, but a monthly cutoff applies for pharmacy software listing. No estimated value provided.

Risks

No estimated value or volume provided – cannot assess potential revenue.

All eligible competitors can participate; high competition may reduce market share.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG.
  • Must have a valid marketing authorization for the offered Ranibizumab products in Germany/EU/EEA.

Eligibility

  • Must submit a signed self-declaration (Anlage 4) confirming eligibility and reliability.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Biologika Rabattverträge 2026 - 15 Ranibizumab

Conclusion of discount contracts with all eligible pharmaceutical entrepreneurs for the active substance Ranibizumab. No exclusivity, uniform conditions, no individual negotiations.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jun 2026 - Jun 2027

Category

Pharmaceutical products

Deadline

Deadline Jun 30, 2027

Procurement Details

Publication date
18 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
342650-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24